IL-10 plays opposing roles during staphylococcus aureus systemic and localized infections

Journal of Immunology

Volumn 198, Issue 6, 2017, Pages 2352-2365

  Leech, John M ^a   Lacey, Keenan A ^a   Mulcahy, Michelle E ^a   Medina, Eva ^b   McLoughlin, Rachel M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; BACTERIAL TRANSMISSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOREGULATION; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; ACUTE DISEASE; ANIMAL; BACTEREMIA; BIOFILM; C57BL MOUSE; COMPLICATION; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PERITONITIS; REGULATORY B LYMPHOCYTE; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; VIROLOGY;

ACUTE DISEASE; ANIMALS; B-LYMPHOCYTES, REGULATORY; BACTEREMIA; BIOFILMS; HUMANS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2;

EID: 85014625150     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601018     Document Type: Article

References (51)

1. Sabat, R., G. Grutz, K. Warszawska, S. Kirsch, E. Witte, K. Wolk, and J. Geginat. 2010. Biology of interleukin-10. Cytokine Growth Factor Rev. 21: 331-344.
2. Ouyang, W., S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29: 71-109.
3. Kuhn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
4. Sellon, R. K., S. Tonkonogy, M. Schultz, L. A. Dieleman, W. Grenther, E. Balish, D. M. Rennick, and R. B. Sartor. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66: 5224-5231.
5. Sewnath, M. E., D. P. Olszyna, R. Birjmohun, F. J. ten Kate, D. J. Gouma, and T. van Der Poll. 2001. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J. Immunol. 166: 6323-6331.
6. Gazzinelli, R. T., M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R. Kuhn, W. Muller, G. Trinchieri, and A. Sher. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-g and TNF-a. J. Immunol. 157: 798-805.
7. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311-3316.
8. Li, C., I. Corraliza, and J. Langhorne. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67: 4435-4442.
9. O'Leary, S., M. P. O'Sullivan, and J. Keane. 2011. IL-10 blocks phagosome maturation in Mycobacterium tuberculosis-infected human macrophages. Am. J. Respir. Cell Mol. Biol. 45: 172-180.
10. Redford, P. S., A. Boonstra, S. Read, J. Pitt, C. Graham, E. Stavropoulos, G. J. Bancroft, and A. O'Garra. 2010. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 40: 2200-2210.
11. Ross, P. J., E. C. Lavelle, K. H. Mills, and A. P. Boyd. 2004. Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect. Immun. 72: 1568-1579.
12. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195: 221-231.
13. Higgs, R., S. C. Higgins, P. J. Ross, and K. H. G. Mills. 2012. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 5: 485-500.
14. Coleman, M. M., C. M. Finlay, B. Moran, J. Keane, P. J. Dunne, and K. H. Mills. 2012. The immunoregulatory role of CD4+FoxP3+CD252 regulatory T cells in lungs of mice infected with Bordetella pertussis. FEMS Immunol. Med. Microbiol. 64: 413-424.
15. Brown, A. F., J. M. Leech, T. R. Rogers, and R. M. McLoughlin. 2014. Staphylococcus aureus colonization: modulation of host immune response and impact on human vaccine design. Front. Immunol. 4: 507.
16. Melzer, M., and C. Welch. 2013. Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia. J. Hosp. Infect. 84: 143-150.
17. Thammavongsa, V., H. K. Kim, D. Missiakas, and O. Schneewind. 2015. Staphylococcal manipulation of host immune responses. Nat. Rev. Microbiol. 13: 529-543.
18. Foster, T. J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3: 948-958.
19. Li, Z., A. G. Peres, A. C. Damian, and J. Madrenas. 2015. Immunomodulation and disease tolerance to Staphylococcus aureus. Pathogens 4: 793-815.
20. Ziegler, C., O. Goldmann, E. Hobeika, R. Geffers, G. Peters, and E. Medina. 2011. The dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergy. EMBO Mol. Med. 3: 652-666.
21. Tebartz, C., S. A. Horst, T. Sparwasser, J. Huehn, A. Beineke, G. Peters, and E. Medina. 2015. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. J. Immunol. 194: 1100-1111.
22. Heim, C. E., D. Vidlak, T. D. Scherr, J. A. Kozel, M. Holzapfel, D. E. Muirhead, and T. Kielian. 2014. Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection. J. Immunol. 192: 3778-3792.
23. Heim, C. E., D. Vidlak, and T. Kielian. 2015. Interleukin-10 production by myeloid-derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection. J. Leukoc. Biol. 98: 1003-1013.
24. Heim, C. E., D. Vidlak, T. D. Scherr, C. W. Hartman, K. L. Garvin, and T. Kielian. 2015. IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection. J. Immunol. 194: 3861-3872.
25. Kamanaka, M., S. T. Kim, Y. Y. Wan, F. S. Sutterwala, M. Lara-Tejero, J. E. Galán, E. Harhaj, and R. A. Flavell. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952.
26. Mulcahy, M. E., J. A. Geoghegan, I. R. Monk, K. M. O'Keeffe, E. J. Walsh, T. J. Foster, and R. M. McLoughlin. 2012. Nasal colonisation by Staphylococcus aureus depends upon clumping factor B binding to the squamous epithelial cell envelope protein loricrin. PLoS Pathog. 8: e1003092.
27. Tzianabos, A. O., J. Y. Wang, and J. C. Lee. 2001. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Natl. Acad. Sci. USA 98: 9365-9370.
28. Thurlow, L. R., M. L. Hanke, T. Fritz, A. Angle, A. Aldrich, S. H. Williams, I. L. Engebretsen, K. W. Bayles, A. R. Horswill, and T. Kielian. 2011. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186: 6585-6596.
29. Richardson, M. P., M. J. Ayliffe, M. Helbert, and E. G. Davies. 1998. A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test. J. Immunol. Methods 219: 187-193.
30. Murphy, A. G., K. M. O'Keeffe, S. J. Lalor, B. M. Maher, K. H. Mills, and R. M. McLoughlin. 2014. Staphylococcus aureus infection of mice expands a population of memory gd T cells that are protective against subsequent infection. [Published erratum appears in 2015 J. Immunol. 194: 4588.] J. Immunol. 192: 3697-3708.
31. O'Keeffe, K. M., M. M. Wilk, J. M. Leech, A. G. Murphy, M. Laabei, I. R. Monk, R. C. Massey, J. A. Lindsay, T. J. Foster, J. A. Geoghegan, and R. M. McLoughlin. 2015. Manipulation of autophagy in phagocytes facilitates Staphylococcus aureus bloodstream infection. Infect. Immun. 83: 3445-3457.
32. Brown, A. F., A. G. Murphy, S. J. Lalor, J. M. Leech, K. M. O'Keeffe, M. Mac Aogáin, D. P. O'Halloran, K. A. Lacey, M. Tavakol, C. H. Hearnden, et al. 2015. Memory Th1 cells are protective in invasive Staphylococcus aureus infection. PLoS Pathog. 11: e1005226.
33. Peres, A. G., C. Stegen, J. Li, A. Q. Xu, B. Levast, M. G. Surette, B. Cousineau, M. Desrosiers, and J. Madrenas. 2015. Uncoupling of pro-and anti-inflammatory properties of Staphylococcus aureus. Infect. Immun. 83: 1587-1597.
34. Cho, J. S., E. M. Pietras, N. C. Garcia, R. I. Ramos, D. M. Farzam, H. R. Monroe, J. E. Magorien, A. Blauvelt, J. K. Kolls, A. L. Cheung, et al. 2010. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120: 1762-1773.
35. Rigby, K. M., and F. R. DeLeo. 2012. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 34: 237-259.
36. Gresham, H. D., J. H. Lowrance, T. E. Caver, B. S. Wilson, A. L. Cheung, and F. P. Lindberg. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 164: 3713-3722.
37. Krause, P., V. Morris, J. A. Greenbaum, Y. Park, U. Bjoerheden, Z. Mikulski, T. Muffley, J. W. Shui, G. Kim, H. Cheroutre, et al. 2015. IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis. Nat. Commun. 6: 7055.
38. Chan, L. C., S. Chaili, S. G. Filler, K. Barr, H. Wang, D. Kupferwasser, J. E. Edwards, Jr., Y. Q. Xiong, A. S. Ibrahim, L. S. Miller, et al. 2015. Nonredundant roles of interleukin-17A (IL-17A) and IL-22 in murine host defense against cutaneous and hematogenous infection due to methicillin-resistant Staphylococcus aureus. Infect. Immun. 83: 4427-4437.
39. Lacey, K. A., J. A. Geoghegan, and R. M. McLoughlin. 2016. The role of Staphylococcus aureus virulence factors in skin infection and their potential as vaccine antigens. Pathogens 5: 22.
40. Montgomery, C. P., M. Daniels, F. Zhao, M. L. Alegre, A. S. Chong, and R. S. Daum. 2014. Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infect. Immun. 82: 2125-2134.
41. Geherin, S. A., D. Gómez, R. A. Glabman, G. Ruthel, A. Hamann, and G. F. Debes. 2016. IL-10+ innate-like B cells are part of the skin immune system and require a4b1 integrin to migrate between the peritoneum and inflamed skin. J. Immunol. 196: 2514-2525.
42. Girard-Madoux, M. J., J. M. Kel, B. Reizis, and B. E. Clausen. 2012. IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity. J. Allergy Clin. Immunol. 129: 143-150.e10.
43. Manicassamy, S., and B. Pulendran. 2011. Dendritic cell control of tolerogenic responses. Immunol. Rev. 241: 206-227.
44. Frodermann, V., T. A. Chau, S. Sayedyahossein, J. M. Toth, D. E. Heinrichs, and J. Madrenas. 2011. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J. Infect. Dis. 204: 253-262.
45. Schoenlaub, L., A. Elliott, D. Freches, W. J. Mitchell, and G. Zhang. 2015. Role of B cells in host defense against primary Coxiella burnetii infection. Infect. Immun. 83: 4826-4836.
46. Pfau, J. C., K. Hurley, C. Peterson, L. Coker, C. Fowers, and R. Marcum. 2014. Activation and trafficking of peritoneal B1a B-cells in response to amphibole asbestos. J. Immunotoxicol. 11: 90-98.
47. Crane, D. D., A. J. Griffin, T. D. Wehrly, and C. M. Bosio. 2013. B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses. J. Immunol. 190: 2756-2766.
48. Maseda, D., K. M. Candando, S. H. Smith, I. Kalampokis, C. T. Weaver, S. E. Plevy, J. C. Poe, and T. F. Tedder. 2013. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-g+CD4+ T cell numbers during colitis development in mice. J. Immunol. 191: 2780-2795.
49. Zhang, X. 2013. Regulatory functions of innate-like B cells. Cell. Mol. Immunol. 10: 113-121.
50. Gao, J., X. Ma, W. Gu, M. Fu, J. An, Y. Xing, T. Gao, W. Li, and Y. Liu. 2012. Novel functions of murine B1 cells: active phagocytic and microbicidal abilities. Eur. J. Immunol. 42: 982-992.
51. Yimin, M., M. Kohanawa, S. Zhao, M. Ozaki, S. Haga, G. Nan, Y. Kuge, and N. Tamaki. 2013. Contribution of Toll-like receptor 2 to the innate response against Staphylococcus aureus infection in mice. PLoS One 8: e74287.